Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.2 |
mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.2 |
mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.15 | 0.2 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |